A recent study investigated the potential therapeutic benefits of GLP-1 RA on oxidative stress, mitochondrial respiration leukocyte–endothelial interactions, inflammation, and carotid intima-media thickness (CIMT) in T2D patients. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.